Literature DB >> 126552

Antibodies to peptidoglycan in the sera from population surveys.

W Schachenmayr, B Heymer, O Haferkamp.   

Abstract

A recently described latex agglutination test was used to determine peptidoglycan antibody titers in sera from healthy human subjects and in sera from patients with a history of streptococcal infections or rheumatoid arthritis. Using latex particles coated with group A streptococcal peptidoglycan 32.8% of the sera from 961 healthy donors reacted positively with titers ranging from 1 : 5 to 1 : 320. Peptidoglycan antibodies were more frequently present in the younger population (45.1% in the 20-29 years old) and considerably decreased in advanced age (15.7% in the 70 years or older). Sera from 82 patients with elevated ASO-titers showed detectable peptidoglycan antibody levels in 40.2%; a statistically significant correlation between ASO and peptidoglycan antibody titers could not be substantiated. Sera from 25 patients with rheumatoid arthritis gave a high incidence (56-92%) of positive results. However there was evidence that this may be due to the action of rheumatoid factor present in such sera.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126552

Source DB:  PubMed          Journal:  Z Immunitatsforsch Exp Klin Immunol        ISSN: 0300-872X


  4 in total

Review 1.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 2.  Molecular mechanisms in endotoxin fever.

Authors:  C A Dinarello
Journal:  Agents Actions       Date:  1983-08

3.  Complement consumption gonococcal peptidoglycan.

Authors:  B H Petersen; R S Rosenthal
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

4.  Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy.

Authors:  G M Bahr; F Z Modabber; G A Rook; M L Mehrotra; J L Stanford; L Chedid
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.